Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Richard Russell (Lymington, United Kingdom), Richard Russell, David Price, Rafael Mares, Anne Burden, Derek Skinner, Helga Mikkelsen, Niels H. Chavannes, Janwillem W.H. Kocks, Jeffrey W. Stephens, John Haughney. Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study. Eur Respir J 2016; 48: Suppl. 60, 867

Member's Comments

No comment yet.

Related content which might interest you: Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs Source: International Congress 2014 – COPD: points to ponder Year: 2014 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Impact of diabetes in patients with COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Comorbidities in patients with COPD and their impact on COPD course Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Comorbidities and COPD severity: The French Palomb cohort Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Late Breaking Abstract - The cost, health resources utilization and medications in chronic obstructive pulmonary patients with diabetes mellitus: a population-based cohort study in Taiwan. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Prevalence of common diseases in COPD patients versus lung-healthy control subjects: Results from the German COSYCONET study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Comparison of comorbidities between two different subgroups in combined assessment of COPD Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016